Assignee
ADAMAS PHARMACEUTICALS INC
US·20 granted patents·41 pending applications·382 citations·filing 2005–2021
Top patents by PatentIndex Score
61 records- 0199US9072697B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2015·Granted Jul 7, 2015·22 cites·16 claims
- 0298US8987333B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Mar 24, 2015·20 cites·11 claims
- 0398US8895617B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·17 claims
- 0498US8895618B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·12 claims
- 0598US8895616B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·14 claims
- 0698US8895615B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·16 claims
- 0798US8895614B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·11 claims
- 0898US8889740B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 18, 2014·21 cites·9 claims
- 0998US8796337B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2013·Granted Aug 5, 2014·27 cites·14 claims
- 1098US7619007B2Method and composition for administering an NMDA receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2005·Granted Nov 17, 2009·53 cites·20 claims
- 1197US8580858B2Compositions for the treatment of CNS-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2012·Granted Nov 12, 2013·22 cites·10 claims
- 1297US8362085B2Method for administering an NMDA receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2012·Granted Jan 29, 2013·33 cites·12 claims
- 1396US8598233B2Method for administering an NMDA receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2013·Granted Dec 3, 2013·21 cites·18 claims
- 1492US7981930B2Compositions and kits for treating influenzaADAMAS PHARMACEUTICALS INC·Filed 2008·Granted Jul 19, 2011·22 cites·7 claims
- 1592US7858660B2Compositions and kits for treating influenzaADAMAS PHARMACEUTICALS INC·Filed 2009·Granted Dec 28, 2010·20 cites·44 claims
- 1688US10987324B2Methods and compositions for the treatment of seizure-related disordersADAMAS PHARMACEUTICALS INC·Filed 2018·Granted Apr 27, 2021·3 cites·18 claims
- 1786US7326730B2Aminoadamantane derivatives as therapeutic agentsADAMAS PHARMACEUTICALS INC·Filed 2005·Granted Feb 5, 2008·7 cites·13 claims
- 1880US10973783B2Methods and compositions for the treatment of seizure-related disordersADAMAS PHARMACEUTICALS INC·Filed 2016·Granted Apr 13, 2021·1 cites·34 claims
- 1975US11890261B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2021·Granted Feb 6, 2024·0 cites·18 claims
- 2074US2014135529A1Method for administering an nmda receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2173US2017151189A1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2273US2017151188A1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2372US2013165517A1Composition and Method for Treating Neurological DiseaseADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2470US2015045446A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2570US2015051292A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2670US2015045438A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2770US2015045439A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2870US2015045448A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2970US2015045447A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3070US2015057355A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3169US2014336266A1Method for administering an nmda receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3269US2016263052A1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3369US2016263058A1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3469US2014242163A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3569US2016256413A1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3667US2014134243A1Compositions for the Treatment of CNS-Related ConditionsADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3767US2014179797A1Composition for Administering an NMDA Receptor Antagonist to a SubjectADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3866US2016243093A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3966US2016250149A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4066US2016243094A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4166US2016243035A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4266US2016220545A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4366US2016243058A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4466US2016250161A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4566US2022062204A1Methods and compositions for the treatment of seizure-related disordersADAMAS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4666US2016243095A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4764US11833121B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2020·Granted Dec 5, 2023·0 cites·16 claims
- 4864US2016263053A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4964US2016256414A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 5064US2017056340A1Composition for Administering an NMDA Receptor Antagonist to a SubjectADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →